Trial Profile
Prospective study to investigate effectiveness of intra-arterial administration of fasudil hydrochloride (IAFC) for prevention of symptomatic vasospasm after subarachnoid hemorrhage
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Fasudil (Primary)
- Indications Cerebral vasospasm
- Focus Therapeutic Use
- 09 Dec 2015 New trial record